Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 3, 1996, Pages 368-375

  Nakamura, Masahiko ^a   Xue, YiXue ^a   Eto, Koji ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

D Disopyramide; L Disopyramide; Na channel; Ventricular arrhythmia

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGITALIS; DISOPYRAMIDE; OUABAIN;

ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; ENANTIOMER; FEMALE; HEART RATE; HEART VENTRICLE TACHYCARDIA; INTRAVENOUS DRUG ADMINISTRATION; ISOMER; MALE; NONHUMAN; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CORONARY DISEASE; DIGITALIS; DISOPYRAMIDE; DOGS; ELECTROCARDIOGRAPHY; FEMALE; MALE; PLANTS, MEDICINAL; PLANTS, TOXIC; STEREOISOMERISM;

EID: 0029928099     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199603000-00009     Document Type: Article

References (32)

1. Vaughan WEM. Subgroups of class I antiarrhythmic drugs. Eur Heart J 1984;5:96-9.
2. Heel RC, Brogden RN, Speight TM, Avery GS. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs 1978;15: 331-68.
3. Giacomini JC, Cox BM, Blaschke TF. Comparative anticholinergic potencies of R- and S-disopyramide in longitudinal muscle strips from guinea pig ileum. Life Sci 1980;27: 1191-7.
4. Nelson WL, Sneed CK, Giacomini KM, et al. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropy-lamino)-2-(2-pyridyl)-2-phenyl-butylamide, the mono-N-dealkylated metabolite of disopyramide. J Med Chem 1981; 24:614-7.
5. Vanhoutte F, Vereecke J, Carmeliet E, Verbeke N. Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol 1991;344:662-73.
6. Hashimoto K. Electrophysiological correlates of antiarrhythmic effects of drugs and pharmacokinetic principles ex- amined using canine ventricular arrhythmias. In: Papp JGY, ed. Cardiovascular Pharmacology '87. 1987:79-93.
7. Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc Drugs Ther 1991;5:805-18.
8. Le Corre P, Gibassier D, Descaves C, Sado P, Daubert JC, Le Verge R. Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias. J Clin Pharmacol 1989;29:1089-96.
9. Hashimoto K, Ishii M, Komori S, Mitsuhashi H. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Heart Vessels 1985;1:29-35.
10. Hashimoto K, Satoh H, Shibuya T, Imai S. Canine effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia. J Pharmacol Exp Ther 1982;223:801-10.
11. Harris AS. Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1950;1:1318-29.
12. Le Corre P, Gibassier D, Sado P, Le Verge R. Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography: application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man. J Chromatogr 1988;450:211-6.
13. Le Corre P, Gibassier D, Sado P, Le Verge R. Simultaneous assay of disopyramide and monodesisopropyldisopyramide enantiomers in biological samples by liquid chromatography. J Chromatogr 1988;424:424-9.
14. Scheffé HA. A method for judging all possible contrasts in the analysis of variance, Biometrika 1953;40:87-104.
15. Singh BN, Hauswirth Q. Comparative mechanism of action of antiarrhythmic drugs. Am Heart J 1974;87:367-82.
16. Sheldon RS, Cannon NJ, Duff HJ. A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels. Circ Res 1987;61:492-7.
17. Huang JD, Oie S. Comparison of electrocardiographic response and disposition of R- and 5-disopyramide in the rabbit. Res Commun Chem Pathol Pharmacol 1983;41:227-41.
18. Mirro MJ, Watanabe AM, Bailey JC. Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry. Circ Res 1981; 48:867-74.
19. Kidwell GA, Schaal SF, Muir WW III. Stereospecific effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine. J Cardiovasc Pharmacol 1987;9:276-84.
20. Rahn KH. Haemodynamic effects of the optical isomers of beta-receptor blocking agents. Eur Heart J 1983;4(suppl D): 27-30.
21. Chiba S, Kobayashi M, Furukawa Y. Effects of optical isomers of verapamil on SA nodal pacemaker activity and contractility of the isolated dog heart. Jpn Heart J 1978;19:409-14.
22. Block AJ, Merrill D, Smith ER. Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro. J Cardiovasc Pharmacol 1988;11:216-21.
23. Haruno A, Matsuzaki T, Hashimoto K. Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias. J Cardiovasc Pharmacol 1990;16:376-32.
24. Carmeliet E, Saikawa T. Shortening of the action potential and reduction of the pacemaker activity by lidocaine, quinidine, and procainamide in sheep cardiac Purkinje fibers. An effect on Na or K currents? Circ Res 1982;50:257-72.
25. Lima JJ, Boudoulas H. Stereoselective effects of disopyramide enantiomers in humans. J Cardiovasc Pharmacol 1987; 9:594-600.
26. Pollick C, Giacomini KM, Blaschke TF, et al. The cardiac effects of D- and L-disopyramide in normal subjects: a non invasive study. Circulation 1982;66:447-53.
27. Lima JJ, Wenzke SC, Boudoulas H, Schaal SF. Antiarrhythmic activity and unbound concentrations of disopyramide enantiomers in patients. Ther Drug Monit 1990;12:23-8.
28. Julian IDG. The arrhythmogenic effects of antiarrhythmic drugs. Eur Heart J 1988;9(suppl):1-4.
29. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of ecainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
30. Echt DS, Liebson PR, Mitchell LB, et al. The CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-8.
31. Mirro MJ, Manalan AS, Bailey JC, Watanabe AM. Anticholinergic effects of disopyramide and quinidine on guinea-pig myocardium. Mediation by direct muscarinic receptor blockade. Circ Res 1980;47:855-65.
32. Kidwell GA, Lima JJ, Schaal SF, Muir WW III. Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model. J Cardiovasc Pharmacol 1989;13:644-55.